0001193125-07-054116 Sample Contracts

Pursuant to 17 CFR 240.24b-2, confidential information has been omitted in places marked “[* * *]” and has been filed separately with the Securities and Exchange Commission pursuant to a Confidential Treatment Application filed with the Commission....
Supply and Distribution Agreement • March 14th, 2007 • Spectrum Pharmaceuticals Inc • Pharmaceutical preparations • New York

This SUPPLY AND DISTRIBUTION AGREEMENT dated as of the 10th day of November, 2006 (the “Execution Date”) by and among Glaxo Group Limited, a company incorporated in England and Wales, having its registered office at Glaxo Wellcome House, Berkeley Avenue, Greenford, Middlesex, England UB6 0NN, and Glaxo Wellcome Manufacturing PTE Limited, having its registered office at 1 Pioneer Sector 1, Jurong, Singapore 628413 (collectively, “GSK”), and PAR Pharmaceutical Companies, Inc., a Delaware corporation having its office at 300 Tice Boulevard, 3rd Floor, Woodcliff Lake, NJ 07677 (“PAR”). PAR and GSK are sometimes collectively referred to herein as the “Parties” and separately as a “Party.”

AutoNDA by SimpleDocs
FIRST AMENDMENT TO THE DEVELOPMENT AND MARKETING AGREEMENT
Development and Marketing Agreement • March 14th, 2007 • Spectrum Pharmaceuticals Inc • Pharmaceutical preparations • New York

This First Amendment (“Amendment”) to the Development and Marketing Agreement (“Agreement”) dated February 22, 2006, by and between Spectrum Pharmaceuticals, Inc. (“Spectrum”) and Par Pharmaceutical, Inc. (“Par”) is entered into and is effective as of November 10, 2006 (“First Amendment Effective Date”), hereinafter referred to as “Party” and, collectively, as “Parties.” Capitalized terms used but not defined herein shall have the meanings given them in the Agreement.

Draft better contracts in just 5 minutes Get the weekly Law Insider newsletter packed with expert videos, webinars, ebooks, and more!